The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Rapamycin inhibits FBXW7 loss-induced epithelial–mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rapamycin inhibits cell proliferation, epithelial-mesenchymal transition and cancer stem cell characteristics of lung cancer stem cells and colorectal cancer stem cells 93,94”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Welcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084
Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene
Mao, J.-H., Perez-losada, J., Wu, D., DelRosario, R., Tsunematsu, R., Nakayama, K. I., Brown, K., Bryson, S., & Balmain, A. (2004) · Nature · doi:10.1038/nature03155 · Cited by 390
Self-citation
Research works printed but not linked: 20
- Thiery, 2002, Epithelial–mesenchymal transitions in tumour progression, Nat. Rev. Cancer, 2, 442, 10.1038/nrc822 · DOI
- Thiery, 2009, Epithelial–mesenchymal transitions in development and disease, Cell, 139, 871, 10.1016/j.cell.2009.11.007 · DOI · Paper page
- Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167 · DOI · Paper page
- Abdullah, 2013, Mechanisms of chemoresistance in cancer stem cells, Clin. Transl. Med., 2, 3, 10.1186/2001-1326-2-3 · DOI
- Mani, 2008, The epithelial–mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016/j.cell.2008.03.027 · DOI
- Cheng, 2012, Role of the ubiquitin ligase Fbw7 in cancer progression, Cancer Metastasis Rev., 31, 75, 10.1007/s10555-011-9330-z · DOI
- Tetzlaff, 2004, Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein, Proc. Natl. Acad. Sci. USA, 101, 3338, 10.1073/pnas.0307875101 · DOI
- Tsunematsu, 2004, Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development, J. Biol. Chem., 279, 9417, 10.1074/jbc.M312337200 · DOI
- Rajagopalan, 2004, Inactivation of hCDC4 can cause chromosomal instability, Nature, 428, 77, 10.1038/nature02313 · DOI
- Rice, 2012, Metastasis: the rude awakening, Nature, 485, S55, 10.1038/485S55a · DOI
- Gulhati, 2011, MTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways, Cancer Res., 71, 3246, 10.1158/0008-5472.CAN-10-4058 · DOI
- Mao, 2008, FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression, Science, 321, 1499, 10.1126/science.1162981 · DOI
- Liu, 2013, Temporal mTOR inhibition protects Fbxw7-deficient mice from radiation-induced tumor development, Aging (Albany, NY), 5, 111, 10.18632/aging.100535 · DOI
- Arabi, 2012, Proteomic screen reveals Fbw7 as a modulator of the NF-kappaB pathway, Nat. Commun., 3, 976, 10.1038/ncomms1975 · DOI · Paper page
- A.B. D’Assoro, T. Liu, C. Quatraro, A. Amato, M. Opyrchal, A. Leontovich, Y. Ikeda, S. Ohmine, W. Lingle, V. Suman, J. Ecsedy, I. Iankov, A. Di Leonardo, J. Ayers-Inglers, A. Degnim, D. Billadeau, J. McCubrey, J. Ingle, J.L. Salisbury, E. Galanis, The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERalpha(+) breast cancer cells. Oncogene (2013). [Epub ahead of print] · DOI
- Chou, 2013, Chromosome Instability Modulated by BMI1-AURKA Signaling Drives Progression in Head and Neck Cancer, Cancer Res., 73, 953, 10.1158/0008-5472.CAN-12-2397 · DOI
- Wang, 2012, Overexpression of Aurora-A enhances invasion and matrix metalloproteinase-2 expression in esophageal squamous cell carcinoma cells, Mol. Cancer Res., 10, 588, 10.1158/1541-7786.MCR-11-0416 · DOI
- Kwon, 2012, Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development, Mol. Cancer Res., 10, 834, 10.1158/1541-7786.MCR-12-0025 · DOI
- Lu, 2012, MiR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming of mouse fibroblast cells to iPSCs, PLoS One, 7, e40938, 10.1371/journal.pone.0040938 · DOI
- Okita, 2012, Increased efficiency in the generation of induced pluripotent stem cells by Fbxw7 ablation, Genes Cells, 17, 768, 10.1111/j.1365-2443.2012.01626.x · DOI
Cited by
Sorted by citations
Targeting the biology of aging with mTOR inhibitors
Mannick, J. B., & Lamming, D. W. (2023) · Nature Aging · doi:10.1038/s43587-023-00416-y · Cited by 372
Metadata
- Authors
- Wang, Y., Liu, Y., Lu, J., Zhang, P., Wang, Y., Xu, Y., Wang, Z., Mao, J.-H., & Wei, G.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 434
- Issue
- 2
- Pages
- 352-356
- ISSN
- 0006-291X
- PMC
- PMC3646979
- Cited by
- 69
- References
- 3
- Language
- en
- Funders
- National Natural Science Foundation of China (31271461, 81172528)
- National Institutes of Health
- Ministry of Education of the People's Republic of China (20110131110035)
- U.S. Department of Energy (DE-AC02-05CH11231)
- Natural Science Foundation of Shandong Province (ZR2011HM034)
- National Cancer Institute (R01 CA116481)
- Laboratory Directed Research and Development
- Biological and Environmental Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review